Healthcare provider profile · identity verified

Stephen Merrill Causey, MD

Family Practice · MOUNT PLEASANT, NC · NPI 1831451814

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	501	104
Lisinopril	Lisinopril	453	95
Amlodipine Besylate	Amlodipine Besylate	436	97
Omeprazole	Omeprazole	401	92
Metformin Hcl Er	Metformin Hcl	276	57
Levothyroxine Sodium	Levothyroxine Sodium	272	57
Losartan Potassium	Losartan Potassium	247	57
Gabapentin	Gabapentin	233	48
Hydrochlorothiazide	Hydrochlorothiazide	233	59
Eliquis	Apixaban	204	36
Metoprolol Tartrate	Metoprolol Tartrate	185	42
Rosuvastatin Calcium	Rosuvastatin Calcium	181	52
Simvastatin	Simvastatin	160	32
Montelukast Sodium	Montelukast Sodium	157	34
Jardiance	Empagliflozin	146	23
Metoprolol Succinate	Metoprolol Succinate	137	31
Furosemide	Furosemide	136	38
Tamsulosin Hcl	Tamsulosin Hcl	133	30
Trazodone Hcl	Trazodone Hcl	125	23
Carvedilol	Carvedilol	119	22
Glipizide	Glipizide	115	22
Potassium Chloride	Potassium Chloride	110	21
Clopidogrel	Clopidogrel Bisulfate	105	22
Metformin Hcl	Metformin Hcl	103	18
Pantoprazole Sodium	Pantoprazole Sodium	101	25
Mounjaro	Tirzepatide	98	15
Hydralazine Hcl	Hydralazine Hcl	96	19
Albuterol Sulfate Hfa	Albuterol Sulfate	93	21
Januvia	Sitagliptin Phosphate	84	12
Zolpidem Tartrate	Zolpidem Tartrate	79	suppressed
Tizanidine Hcl	Tizanidine Hcl	76	20
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	75	suppressed
Meloxicam	Meloxicam	73	18
Pravastatin Sodium	Pravastatin Sodium	72	19
Bupropion Hcl Sr	Bupropion Hcl	71	13
Duloxetine Hcl	Duloxetine Hcl	69	14
Alprazolam	Alprazolam	66	12
Diclofenac Sodium	Diclofenac Sodium	57	15
Sertraline Hcl	Sertraline Hcl	54	16
Tramadol Hcl	Tramadol Hcl	53	11
Venlafaxine Hcl Er	Venlafaxine Hcl	53	11
Escitalopram Oxalate	Escitalopram Oxalate	52	14
Lorazepam	Lorazepam	52	12
Olmesartan Medoxomil	Olmesartan Medoxomil	52	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	51	suppressed
Allopurinol	Allopurinol	50	12
Buspirone Hcl	Buspirone Hcl	50	13
Quetiapine Fumarate	Quetiapine Fumarate	48	suppressed
Fluticasone Propionate	Fluticasone Propionate	47	19
Spironolactone	Spironolactone	47	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	45	suppressed
Ventolin Hfa	Albuterol Sulfate	43	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	42	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	40	12
Warfarin Sodium	Warfarin Sodium	40	suppressed
Citalopram Hbr	Citalopram Hydrobromide	38	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	38	32
Famotidine	Famotidine	37	suppressed
Bupropion Xl	Bupropion Hcl	36	suppressed
Cephalexin	Cephalexin	36	20
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	35	13
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	32	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	32	suppressed
Glimepiride	Glimepiride	28	suppressed
Prednisone	Prednisone	28	25
Torsemide	Torsemide	28	suppressed
Xarelto	Rivaroxaban	28	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	27	suppressed
Celecoxib	Celecoxib	27	suppressed
Mirtazapine	Mirtazapine	27	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	26	suppressed
Finasteride	Finasteride	25	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	25	suppressed
Wegovy	Semaglutide	25	suppressed
Clonazepam	Clonazepam	24	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	24	suppressed
Primidone	Primidone	24	suppressed
Tresiba Flextouch U-200	Insulin Degludec	24	suppressed
Fosinopril Sodium	Fosinopril Sodium	23	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	22	suppressed
Fenofibrate	Fenofibrate	22	suppressed
Novolog Flexpen	Insulin Aspart	22	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	22	suppressed
Pregabalin	Pregabalin	21	suppressed
Synthroid	Levothyroxine Sodium	21	suppressed
Trulicity	Dulaglutide	21	suppressed
Alendronate Sodium	Alendronate Sodium	20	suppressed
Amiodarone Hcl	Amiodarone Hcl	20	suppressed
Donepezil Hcl	Donepezil Hcl	20	suppressed
Eszopiclone	Eszopiclone	20	suppressed
Rybelsus	Semaglutide	20	suppressed
Symbicort	Budesonide/Formoterol Fumarate	20	suppressed
Telmisartan	Telmisartan	20	suppressed
Clonidine Hcl	Clonidine Hcl	19	suppressed
Cefdinir	Cefdinir	18	17
Farxiga	Dapagliflozin Propanediol	18	suppressed
Fluconazole	Fluconazole	18	13
Ondansetron Hcl	Ondansetron Hcl	18	12
Triamcinolone Acetonide	Triamcinolone Acetonide	18	17
Benazepril-Hydrochlorothiazide	Benazepril/Hydrochlorothiazide	17	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	17	suppressed
Qulipta	Atogepant	17	suppressed
Topiramate	Topiramate	17	suppressed
Cyanocobalamin Injection	Cyanocobalamin (Vitamin B-12)	16	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	16	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	16	suppressed
Ozempic	Semaglutide	16	suppressed
Sotalol	Sotalol Hcl	16	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	15	11
Brilinta	Ticagrelor	15	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	15	suppressed
Propranolol Hcl Er	Propranolol Hcl	15	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	14	suppressed
Atomoxetine Hcl	Atomoxetine Hcl	14	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	14	suppressed
Nitroglycerin	Nitroglycerin	14	suppressed
Paroxetine Hcl	Paroxetine Hcl	14	suppressed
Valacyclovir	Valacyclovir Hcl	14	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	13	suppressed
Chlorthalidone	Chlorthalidone	13	suppressed
Enalapril Maleate	Enalapril Maleate	13	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	13	suppressed
Ondansetron Odt	Ondansetron	13	suppressed
Atenolol	Atenolol	12	suppressed
Benazepril Hcl	Benazepril Hcl	12	suppressed
Bupropion Hcl	Bupropion Hcl	12	suppressed
Colchicine	Colchicine	12	suppressed
Ketoconazole	Ketoconazole	12	suppressed
Lovastatin	Lovastatin	12	suppressed
Memantine Hcl	Memantine Hcl	12	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	12	suppressed
Nadolol	Nadolol	12	suppressed
Olanzapine	Olanzapine	12	suppressed
Oxycodone Hcl	Oxycodone Hcl	12	suppressed
Oxycontin	Oxycodone Hcl	12	suppressed
Temazepam	Temazepam	12	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	11	suppressed
Fluvoxamine Maleate	Fluvoxamine Maleate	11	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	11	suppressed
Rabeprazole Sodium	Rabeprazole Sodium	11	suppressed
Solifenacin Succinate	Solifenacin Succinate	11	suppressed
Ubrelvy	Ubrogepant	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error